Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Trial Profile

Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2011

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Fibromyalgia; Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 08 May 2010 Results were presented at the 29th Annual Scientific Meeting of the American Pain Society.
    • 19 Aug 2009 Actual patient number (513) added as reported by ClinicalTrials.gov.
    • 19 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top